{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:32:43Z","timestamp":1787031163118,"version":"build-2736575974"},"reference-count":28,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4254\/wjh.v9.i1.57","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T22:37:52Z","timestamp":1483655872000},"page":"57","source":"Crossref","is-referenced-by-count":13,"title":["Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis"],"prefix":"10.4254","volume":"9","author":[{"given":"Yuichi","family":"Torisu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hokari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Zeniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3283457ce0"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.16.11.876"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.3.319"},{"key":"ref5","unstructured":"Uribe M, Go VL, Kluge D. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects. J Clin Gastroenterol 1984;6:331-335."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lebovics E, Schaffner F, Klion FM, Simon C. Autoimmune chronic active hepatitis in postmenopausal women. Dig Dis Sci 1985;30:824-828.","DOI":"10.1007\/BF01309511"},{"key":"ref7","unstructured":"Wright SH, Czaja AJ, Katz RS, Soloway RD. Systemic mycosis complicating high dose corticosteroid treatment of chronic active liver disease. Am J Gastroenterol 1980;74:428-432."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology 1984;4:622-627.","DOI":"10.1002\/hep.1840040409"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105303242204"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.","DOI":"10.1016\/S0016-5085(97)70183-5"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00634.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-1290.","DOI":"10.1016\/0016-5085(94)90021-3"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-009-9155-9"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Nakamura K, Yoneda M, Yokohama S, Tamori K, Sato Y, Aso K, Aoshima M, Hasegawa T, Makino I. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 1998;13:490-495.","DOI":"10.1111\/j.1440-1746.1998.tb00674.x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300603"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.","DOI":"10.1002\/hep.1840190629"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Jazrawi RP, de Caestecker JS, Goggin PM, Britten AJ, Joseph AE, Maxwell JD, Northfield TC. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994;106:134-142.","DOI":"10.1016\/S0016-5085(94)94899-2"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00092-7"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Kisand KE, Karvonen AL, Vuoristo M, Färkkilä M, Lehtola J, Inkovaara J, Kisand KV, Miettinen T, Krohn K, Uibo R. Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis. J Mol Med (Berl) 1996;74:269-272.","DOI":"10.1007\/BF00196579"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, Ishizaka S. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992;16:358-364.","DOI":"10.1002\/hep.1840160213"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"De Groote J, Fevery J, Lepoutre L. Long-term follow-up of chronic active hepatitis of moderate severity. Gut 1978;19:510-513.","DOI":"10.1136\/gut.19.6.510"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01904.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20732"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol 2002;35:75-81.","DOI":"10.1097\/00004836-200207000-00016"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.07.017"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-011-0421-y"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v9\/i1\/57.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T02:24:56Z","timestamp":1568687096000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v9\/i1\/57.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v9.i1.57","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}